WINTER SPRINGS, Fla., May 29, 2025 - Iradimed Corporation $(IRMD)$, a leading provider of innovative medical devices for MRI environments, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its MRidium® 3870 IV Infusion Pump System. This next-generation, MRI-compatible infusion pump reinforces Iradimed's unique position as the sole supplier of non-magnetic MRI infusion pump devices, a leadership role they have held since the introduction of their first-generation device in 2005. The MRidium® 3870 is designed to enhance patient safety and operational efficiency during MRI procedures, featuring a non-magnetic ultrasonic pump motor and advanced safety features. The company plans a strategic rollout starting in the fourth quarter of 2025, with full commercial distribution expected to increase throughout 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.